chm

(redirected from choroideremia)
Also found in: Dictionary, Medical, Acronyms, Wikipedia.
Related to choroideremia: gyrate atrophy
References in periodicals archive ?
This approach uses a viral vector known as adeno-associated virus (AAV) to deliver a wild-type copy of the Rab-escort protein 1 (REP-1) gene (AAV2-REP1) into the retinal cells of choroideremia patients.
THE FIRST clinical trial into the rare blinding condition choroideremia has started at Oxford Eye Hospital, thanks to a grant from Fight for Sight.
Guests attended a fundraiser to support the Choroideremia Research Foundation Inc.
Forms of RP and other inherited orphan retinal diseases include Usher syndrome, Stargardt's disease, Leber's congenital amaurosis, rod-cone disease, Bardet-Biedl syndrome, Choroideremia, and Retinoschisis, among others.
A fundraiser to benefit the Choroideremia Research Foundation will take place from 5:30 to 8 p.
com 1,2,3,4,7,9 CHOROIDEREMIA See: Macular Diseases; Retinitis Pigmentosa; Visual Impairments CHRIST-SIEMENS-TOURAINE SYNDROME See: Craniofacial Disorders; Ectodermal Dysplasias CHROMOSOME 13 & 18 DISORDERS See also: Chromosome 18 Disorders SOFT Canada: Support Organization for Trisomy 18, 13 and Related Disorders 760 Brant St.
SAN FRANCISCO -- Allie Ging, 37, will start pedaling his bicycle from the Golden Gate Bridge in San Francisco starting Sunday, May 20th, and pedal his way back to his wife and two-year-old son in Long Island, New York, all in the name of finding a cure for Choroideremia, a hereditary degenerative eye disease that attacks the peripheral vision and slowly erodes it over time until total blindness.
Human Clinical Trials to treat Choroideremia ("CHM"), an inherited and currently incurable genetic condition that progressively leads to blindness by damaging the retina of impacted individuals.
20, 2015 /PRNewswire/ -- Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating, genetic diseases, announced today it has initiated enrollment of a Phase 1/2 clinical trial of its product candidate, SPK-CHM, for patients with choroideremia (CHM).
org, Islandia, NY), a private, not for profit organization providing a comprehensive therapeutic equine program using horses to facilitate growth, learning and healing for children and adults with disabilities, for which he is a Board Member and the Choroideremia Research Foundation, Inc.